NCB:F:F-Bank of America Corporation (EUR)

COMMON STOCK | Banks - Diversified |

Last Closing

USD 41.955

Change

-0.52 (-1.22)%

Market Cap

USD 334.92B

Volume

6.36K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Banks - Diversified

Symbol Name Price(Change) Market Cap
CMCI:F JPMORGAN CHASE CO. CDR

+0.60 (+2.94%)

USD 670.37B
CMC:F JPMorgan Chase & Co

+0.45 (+0.20%)

USD 643.78B
NCB0:F BANK OF AMERICA CORP. CDR

+0.20 (+1.36%)

USD 347.03B
ICKB:F IND.+COMM.BK CHINA ADR/20

+0.30 (+2.54%)

USD 284.02B
ICK:F Industrial and Commercial Bank..

+0.02 (+4.03%)

USD 272.70B
EK7A:F AGRICULT.BK H.ADR/25 YC 1

+0.10 (+0.79%)

USD 229.35B
NWT:F Wells Fargo & Company

-0.20 (-0.29%)

USD 228.86B
EK7:F Agricultural Bank of China Lim..

+0.01 (+1.25%)

USD 220.97B
C6TB:F CHINA CON.BANK ADR/20 YC1

+0.30 (+2.00%)

USD 197.90B
C6T:F China Construction Bank Corpor..

N/A

USD 192.51B

ETFs Containing NCB:F

AFRN:PA Amundi Index Solutions - .. 1.82 % 0.00 %

+0.10 (+0.14%)

USD 1.06B
FRNE:F Amundi Index Solutions - .. 1.82 % 0.00 %

+0.08 (+0.14%)

N/A
FRNE:XETRA Amundi Index Solutions - .. 1.82 % 0.00 %

+0.21 (+0.14%)

USD 1.24B
AFRHU:PA Amundi Index Solutions - .. 1.82 % 0.00 %

+0.04 (+0.14%)

N/A
WINC Western Asset Short Durat.. 1.52 % 0.00 %

+0.03 (+0.14%)

USD 0.01B
RUSB:CA RBC Short Term U.S. Corpo.. 1.26 % 0.40 %

-0.01 (0.14%)

CAD 0.29B
UEF7:F UBS ETF - Bloomberg Barcl.. 1.01 % 0.00 %

+0.01 (+0.14%)

USD 0.29B
UEF8:F UBS Barclays US Liquid Co.. 1.01 % 0.00 %

N/A

N/A
UEF8:XETRA UBS Barclays US Liquid Co.. 1.01 % 0.00 %

N/A

USD 0.28B
UEF7:XETRA UBS Barclays US Liquid Co.. 1.01 % 0.00 %

+0.01 (+0.14%)

USD 0.25B
CBUS5:SW UBS(Lux)Fund Solutions .. 1.01 % 0.00 %

+0.02 (+0.14%)

USD 0.25B
CBUS5H:SW UBS(Lux)Fund Solutions .. 1.01 % 0.00 %

N/A

USD 0.04B
CBUS5S:SW UBS(Lux)Fund Solutions .. 1.01 % 0.00 %

+0.06 (+0.14%)

N/A
CBUS5E:SW UBS(Lux)Fund Solutions .. 1.01 % 0.00 %

N/A

N/A
ESGF:CA BMO ESG US Corporate Bond.. 0.99 % 0.00 %

+0.03 (+0.14%)

CAD 0.02B
ZSU:CA BMO Short-Term US IG Corp.. 0.98 % 0.28 %

+0.01 (+0.14%)

CAD 0.17B
RUSB-U:CA 0.92 % 0.00 %

N/A

N/A
QUIG:CA Mackenzie US Investment G.. 0.80 % 0.28 %

-0.18 (0.14%)

CAD 0.52B
SUSD:LSE SSgA SPDR ETFs Europe I p.. 0.64 % 0.00 %

+0.17 (+0.14%)

N/A
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.61 % 0.00 %

+0.19 (+0.14%)

N/A
4UBP:XETRA UBS(Lux)Fund Solutions .. 0.58 % 0.00 %

-0.02 (0.14%)

USD 0.04B
4UBR:XETRA UBS(Lux)Fund Solutions .. 0.58 % 0.00 %

-0.03 (0.14%)

USD 0.03B
CORPS:SW UBS(Lux)Fund Solutions .. 0.58 % 0.00 %

N/A

N/A
UET0:F UBS (Lux) Fund Solutions .. 0.57 % 0.00 %

-0.05 (0.14%)

N/A
UET0:XETRA UBS(Lux)Fund Solutions .. 0.57 % 0.00 %

-0.02 (0.14%)

USD 0.21B
CBSUST:SW UBS(Lux)Fund Solutions .. 0.57 % 0.00 %

-0.01 (0.14%)

N/A
CBSUS:SW UBS(Lux)Fund Solutions .. 0.57 % 0.00 %

-0.01 (0.14%)

N/A
CBSUSE:SW UBS(Lux)Fund Solutions .. 0.57 % 0.00 %

-0.01 (0.14%)

N/A
CBSUSH:SW UBS(Lux)Fund Solutions .. 0.57 % 0.00 %

N/A

N/A
UC76:LSE UBS Barclays US Liquid Co.. 0.54 % 0.00 %

-0.04 (0.14%)

USD 0.09B
UC85:LSE UBS Barclays US Liquid Co.. 0.54 % 0.00 %

-5.25 (0.14%)

USD 0.13B
UEF0:F UBS Barclays US Liquid Co.. 0.52 % 0.00 %

-0.05 (0.14%)

USD 0.15B
UEF9:F UBS Barclays US Liquid Co.. 0.52 % 0.00 %

-0.02 (0.14%)

USD 0.09B
UEF0:XETRA UBS Barclays US Liquid Co.. 0.52 % 0.00 %

-0.06 (0.14%)

USD 0.36B
UEF9:XETRA UBS Barclays US Liquid Co.. 0.52 % 0.00 %

-0.02 (0.14%)

USD 0.08B
CBUSH:SW UBS(Lux)Fund Solutions .. 0.52 % 0.00 %

-0.02 (0.14%)

USD 0.12B
CBUSS:SW UBS(Lux)Fund Solutions .. 0.52 % 0.00 %

-0.02 (0.14%)

USD 0.04B
CBUSE:SW UBS(Lux)Fund Solutions .. 0.52 % 0.00 %

+0.03 (+0.14%)

USD 0.14B
CBUS:SW UBS(Lux)Fund Solutions .. 0.52 % 0.00 %

-0.02 (0.14%)

N/A
CBUSAC:SW UBS(Lux)Fund Solutions .. 0.52 % 0.00 %

-0.03 (0.14%)

N/A
ZIC-U:CA BMO Mid-Term US IG Corpor.. 0.48 % 0.00 %

+0.04 (+0.14%)

N/A
ZIC:CA BMO Mid-Term US IG Corpor.. 0.48 % 0.26 %

+0.01 (+0.14%)

CAD 3.19B
UCRP:F Amundi Index Solutions - .. 0.36 % 0.00 %

-0.05 (0.14%)

N/A
UCRP:PA Amundi Index Solutions - .. 0.36 % 0.00 %

-0.09 (0.14%)

N/A
UCRH:XETRA Amundi Index Solutions - .. 0.36 % 0.00 %

-0.26 (0.14%)

USD 0.35B
SEUC:PA SSgA SPDR ETFs Europe I p.. 0.35 % 0.00 %

+0.01 (+0.14%)

USD 0.89B
SYBD:F SSgA SPDR ETFs Europe I p.. 0.35 % 0.00 %

N/A

USD 0.88B
SYBF:F SSgA SPDR ETFs Europe I p.. 0.35 % 0.00 %

+0.13 (+0.14%)

USD 0.19B
SYBD:XETRA SPDR® Bloomberg 0-3 Year.. 0.35 % 0.00 %

+0.02 (+0.14%)

USD 1.27B
SYBF:XETRA SPDR Barclays 0-3 Year US.. 0.35 % 0.00 %

+0.08 (+0.14%)

USD 0.19B
SUSC:SW SPDR® Bloomberg 0-3 Year.. 0.35 % 0.00 %

-0.06 (0.14%)

USD 0.18B
SEUC:SW SPDR® Bloomberg 0-3 Year.. 0.35 % 0.00 %

+0.04 (+0.14%)

USD 0.91B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.31 % 0.00 %

-0.10 (0.14%)

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.31 % 0.00 %

N/A

USD 0.23B
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.31 % 0.00 %

-0.03 (0.14%)

USD 0.38B
PR1P:XETRA Amundi Index Solutions - .. 0.28 % 0.00 %

-0.03 (0.14%)

USD 0.10B
PRAP:XETRA Amundi Index Solutions - .. 0.28 % 0.00 %

-0.03 (0.14%)

USD 0.09B
PR1P:F Amundi Index Solutions - .. 0.28 % 0.00 %

-0.03 (0.14%)

USD 0.10B
PRAP:F Amundi Index Solutions Si.. 0.28 % 0.00 %

-0.05 (0.14%)

USD 0.09B
EUCO:PA SPDR Barclays Euro Corpor.. 0.20 % 0.00 %

-0.02 (0.14%)

USD 0.88B
SYBC:F SSgA SPDR ETFs Europe I P.. 0.20 % 0.00 %

-0.05 (0.14%)

USD 0.88B
SYBC:XETRA SPDR Barclays Euro Corpor.. 0.20 % 0.00 %

-0.02 (0.14%)

USD 0.78B
ECRP:PA Amundi Index Solutions - .. 0.18 % 0.00 %

-0.03 (0.14%)

USD 4.57B
DECR:F Amundi Index Solutions - .. 0.18 % 0.00 %

+0.03 (+0.14%)

N/A
DECR:XETRA Amundi Index Solutions - .. 0.18 % 0.00 %

-0.13 (0.14%)

USD 0.17B
A4H8:XETRA Amundi Index Solutions - .. 0.18 % 0.00 %

-0.02 (0.14%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Banks - Diversified) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 37.02% 56% F 84% B
Dividend Return 3.27% 9% A- 34% F
Total Return 40.28% 49% F 76% C+
Trailing 12 Months  
Capital Gain 37.92% 55% F 83% B
Dividend Return 3.29% 9% A- 33% F
Total Return 41.21% 47% F 76% C+
Trailing 5 Years  
Capital Gain 32.69% 43% F 65% D
Dividend Return 13.54% 13% F 31% F
Total Return 46.22% 23% F 54% F
Average Annual (5 Year Horizon)  
Capital Gain 14.63% 58% F 74% C
Dividend Return 16.38% 38% F 70% C-
Total Return 1.76% 35% F 52% F
Risk Return Profile  
Volatility (Standard Deviation) 26.39% 58% F 52% F
Risk Adjusted Return 62.09% 38% F 75% C
Market Capitalization 334.92B 94% A 100% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector